Sales تغيير تاريخ
AbbVie USD 14.3B 374M 2023-12
Abbott USD 10.24B 98M 2023-12
ALKERMES USD 377.48M 3.46M 2023-12
Amgen USD 8.2B 1.29B 2023-12
AstraZeneca USD 12.02B 532M 2023-12
Biogen USD 2.39B 144M 2023-12
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Coherus Biosciences USD 91.52M 16.96M 2023-12
Eisai JPY 177.7B 1.09B 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
Endo International USD 497.73M 46.07M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
GlaxoSmithKline GBP 8.05B 95M 2023-12
Infinity Pharmaceuticals USD 583K 148K 2023-06
J&J USD 21.4B 44M 2023-12
Medtronic USD 8.09B 105M 2023-12
Merck USD 14.63B 1.33B 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novartis USD 11.78B 316M 2023-12
Pacira USD 181.24M 17.32M 2023-12
Perrigo USD 1.16B 33.1M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Revance Therapeutics USD 69.8M 13.02M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sanofi EUR 10.92B 1.05B 2023-12
UCB EUR 2.66B 74M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
United Therapeutics USD 614.7M 5.3M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12
Zoetis USD 2.21B 62M 2023-12



AbbVie مبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.